Trial Outcomes & Findings for Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD? (NCT NCT02039843)
NCT ID: NCT02039843
Last Updated: 2023-12-01
Results Overview
The World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) is a standardized measure for assessing health and disability levels. For the WHO-DAS 2.0 36-item, self-administered questionnaire, participants rate the difficulty they experience with each item on a 5-item scale: 'None,' 'Mild,' 'Moderate,' 'Severe' or 'Extreme/cannot do.' Standardized total disability scores ranging from 0 (no disability) to 100 (full disability) are obtained (WHO-DAS 2.0 manual, 2012).
COMPLETED
NA
287 participants
Baseline and every 3 months after dog pairing up to 18 months post-pairing
2023-12-01
Participant Flow
Sixty participants of 287 consented participants were found to be ineligible for study randomization per study inclusion/exclusion criteria, resulting in 227 participants randomized.
Participant milestones
| Measure |
Emotional Support Dog
Participants with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
Participants with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Randomization and Observation Period
STARTED
|
113
|
114
|
|
Randomization and Observation Period
COMPLETED
|
84
|
97
|
|
Randomization and Observation Period
NOT COMPLETED
|
29
|
17
|
|
Pairing With a Study Dog
STARTED
|
84
|
97
|
|
Pairing With a Study Dog
COMPLETED
|
65
|
88
|
|
Pairing With a Study Dog
NOT COMPLETED
|
19
|
9
|
Reasons for withdrawal
| Measure |
Emotional Support Dog
Participants with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
Participants with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Randomization and Observation Period
Adverse Event
|
2
|
0
|
|
Randomization and Observation Period
Death
|
1
|
0
|
|
Randomization and Observation Period
Lost to Follow-up
|
2
|
3
|
|
Randomization and Observation Period
Withdrawal by Subject
|
2
|
3
|
|
Randomization and Observation Period
Other reasons not paired with a study dog
|
22
|
11
|
|
Pairing With a Study Dog
Death
|
1
|
0
|
|
Pairing With a Study Dog
Lost to Follow-up
|
1
|
4
|
|
Pairing With a Study Dog
Withdrawal by Subject
|
4
|
1
|
|
Pairing With a Study Dog
Other reasons for not completing study
|
13
|
4
|
Baseline Characteristics
The number analyzed is different from the analysis population due to one participant missing an assessment.
Baseline characteristics by cohort
| Measure |
Emotional Support Dog
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
Total
n=181 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
49.2 years
STANDARD_DEVIATION 13.25 • n=84 Participants
|
51.8 years
STANDARD_DEVIATION 13.87 • n=97 Participants
|
50.6 years
STANDARD_DEVIATION 13.61 • n=181 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=84 Participants
|
22 Participants
n=97 Participants
|
36 Participants
n=181 Participants
|
|
Sex: Female, Male
Male
|
70 Participants
n=84 Participants
|
75 Participants
n=97 Participants
|
145 Participants
n=181 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
8 Participants
n=84 Participants
|
4 Participants
n=97 Participants
|
12 Participants
n=181 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
74 Participants
n=84 Participants
|
91 Participants
n=97 Participants
|
165 Participants
n=181 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=84 Participants
|
2 Participants
n=97 Participants
|
4 Participants
n=181 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=84 Participants
|
1 Participants
n=97 Participants
|
3 Participants
n=181 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=84 Participants
|
0 Participants
n=97 Participants
|
2 Participants
n=181 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=84 Participants
|
1 Participants
n=97 Participants
|
1 Participants
n=181 Participants
|
|
Race (NIH/OMB)
Black or African American
|
12 Participants
n=84 Participants
|
10 Participants
n=97 Participants
|
22 Participants
n=181 Participants
|
|
Race (NIH/OMB)
White
|
52 Participants
n=84 Participants
|
68 Participants
n=97 Participants
|
120 Participants
n=181 Participants
|
|
Race (NIH/OMB)
More than one race
|
15 Participants
n=84 Participants
|
16 Participants
n=97 Participants
|
31 Participants
n=181 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=84 Participants
|
1 Participants
n=97 Participants
|
2 Participants
n=181 Participants
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0)
|
38.31 units on a scale
STANDARD_DEVIATION 16.23 • n=83 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment.
|
35.78 units on a scale
STANDARD_DEVIATION 16.72 • n=97 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment.
|
36.95 units on a scale
STANDARD_DEVIATION 16.50 • n=180 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment.
|
|
Veterans Rand 12-Item Health Survey - Physical Component Score (VR-12 PCS)
|
40.16 T-score
STANDARD_DEVIATION 9.94 • n=83 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
43.07 T-score
STANDARD_DEVIATION 11.20 • n=97 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
41.73 T-score
STANDARD_DEVIATION 10.71 • n=180 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
|
Veterans Rand 12-Item Health Survey - Mental Component Score (VR-12 MCS)
|
31.11 T-score
STANDARD_DEVIATION 10.62 • n=83 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
30.68 T-score
STANDARD_DEVIATION 10.37 • n=97 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
30.88 T-score
STANDARD_DEVIATION 10.46 • n=180 Participants • The number analyzed is different from the analysis population due to one participant missing an assessment at baseline.
|
PRIMARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) is a standardized measure for assessing health and disability levels. For the WHO-DAS 2.0 36-item, self-administered questionnaire, participants rate the difficulty they experience with each item on a 5-item scale: 'None,' 'Mild,' 'Moderate,' 'Severe' or 'Extreme/cannot do.' Standardized total disability scores ranging from 0 (no disability) to 100 (full disability) are obtained (WHO-DAS 2.0 manual, 2012).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 15
|
43.48 score on a scale
Standard Deviation 17.83
|
36.16 score on a scale
Standard Deviation 17.69
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 18
|
38.05 score on a scale
Standard Deviation 17.79
|
33.43 score on a scale
Standard Deviation 17.38
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Baseline
|
38.31 score on a scale
Standard Deviation 16.23
|
35.78 score on a scale
Standard Deviation 16.72
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 3
|
41.76 score on a scale
Standard Deviation 16.89
|
38.76 score on a scale
Standard Deviation 16.46
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 6
|
41.70 score on a scale
Standard Deviation 17.62
|
36.73 score on a scale
Standard Deviation 16.33
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 9
|
43.07 score on a scale
Standard Deviation 18.74
|
36.90 score on a scale
Standard Deviation 17.29
|
|
World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Month 12
|
40.79 score on a scale
Standard Deviation 17.36
|
36.76 score on a scale
Standard Deviation 17.23
|
PRIMARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The 12-item, self-administered Veterans Rand 12-Item Health Survey (VR-12) assesses health-related quality of life. Two sub-scores are derived: 1) a Physical Component Score (PCS) assessing general health, physical functioning, role limitations, and bodily pain; and 2) a Mental Component Score (MCS) assessing emotional, vitality/mental health and social functioning (Selim et al., 2009). The PCS score is standardized using a T-score transformation with a mean of 50 (which indicates the population mean) and a standard deviation (SD) of 10 to represent the population norm based on U.S. population in 1990. T-scores below 50 represent worse quality of life compared to the U.S. population norm, and those above 50 indicate better quality of life.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Baseline
|
40.16 T-score
Standard Deviation 9.94
|
43.07 T-score
Standard Deviation 11.20
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 9
|
35.35 T-score
Standard Deviation 11.32
|
39.07 T-score
Standard Deviation 11.65
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 18
|
37.30 T-score
Standard Deviation 11.60
|
38.52 T-score
Standard Deviation 11.71
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 3
|
37.14 T-score
Standard Deviation 10.86
|
39.05 T-score
Standard Deviation 11.08
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 6
|
35.78 T-score
Standard Deviation 10.83
|
39.80 T-score
Standard Deviation 11.59
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 12
|
35.73 T-score
Standard Deviation 12.52
|
38.89 T-score
Standard Deviation 11.44
|
|
Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Month 15
|
35.78 T-score
Standard Deviation 11.42
|
39.48 T-score
Standard Deviation 11.43
|
PRIMARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The 12-item, self-administered Veterans Rand 12-Item Health Survey (VR-12) assesses health-related quality of life. Two sub-scores are derived: 1) a Physical Component Score (PCS) assessing general health, physical functioning, role limitations, and bodily pain; and 2) a Mental Component Score (MCS) assessing emotional, vitality/mental health and social functioning (Selim et al., 2009). The MCS score is standardized using a T-score transformation with a mean of 50 (which indicates the population mean) and a standard deviation (SD) of 10 to represent the population norm based on U.S. population in 1990. T-scores below 50 represent worse quality of life compared to the U.S. population norm, and those above 50 indicate better quality of life.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 6
|
36.71 T-score
Standard Deviation 11.30
|
35.71 T-score
Standard Deviation 8.91
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 18
|
39.04 T-score
Standard Deviation 12.35
|
40.28 T-score
Standard Deviation 9.33
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Baseline
|
31.11 T-score
Standard Deviation 10.62
|
30.68 T-score
Standard Deviation 10.37
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 3
|
35.59 T-score
Standard Deviation 10.32
|
35.81 T-score
Standard Deviation 9.07
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 9
|
34.53 T-score
Standard Deviation 10.59
|
36.39 T-score
Standard Deviation 9.92
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 12
|
37.32 T-score
Standard Deviation 10.66
|
36.98 T-score
Standard Deviation 10.83
|
|
Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Month 15
|
36.42 T-score
Standard Deviation 10.15
|
37.72 T-score
Standard Deviation 11.40
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The Pittsburgh Sleep Quality Index (PSQI) is a self-administered survey used to assess sleep-related problems during the past month (Buysse, et al., 1989). The 19 items completed by the participant are grouped into seven components: (1) Sleep quality, (2) Sleep latency, (3) Sleep duration, (4) Habitual sleep efficiency, (5) Sleep disturbances, (6) Use of sleep medication, and (7) Daytime dysfunction. Each of the seven components are weighted equally on a 0-3 scale with 0 (better) to 3 (worse). These are summed to yield a global score with a range of 0-21 with higher scores indicating worse sleep quality.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 15
|
12.91 score on a scale
Standard Deviation 4.64
|
12.02 score on a scale
Standard Deviation 4.50
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Baseline
|
14.26 score on a scale
Standard Deviation 4.09
|
13.60 score on a scale
Standard Deviation 3.85
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 3
|
13.60 score on a scale
Standard Deviation 4.79
|
12.51 score on a scale
Standard Deviation 4.24
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 6
|
13.10 score on a scale
Standard Deviation 4.60
|
12.17 score on a scale
Standard Deviation 4.13
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 9
|
13.29 score on a scale
Standard Deviation 4.59
|
12.36 score on a scale
Standard Deviation 4.37
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 12
|
13.24 score on a scale
Standard Deviation 4.88
|
12.27 score on a scale
Standard Deviation 4.34
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Month 18
|
12.54 score on a scale
Standard Deviation 4.85
|
11.74 score on a scale
Standard Deviation 4.33
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) is a 20-item self-report measure that assesses the 20 Diagnostic and Statistical Manual of Mental Disorder, 5th edition (DSM-5) symptoms of PTSD. Each symptom is scored on a scale of 0 (not at all) through 4 (extreme). A total symptom severity score is calculated by summing the scores for each of the 20 items. Scores can range from 0 to 80 with higher scores representing greater PTSD symptom severity.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 3
|
41.96 score on a scale
Standard Deviation 15.45
|
41.54 score on a scale
Standard Deviation 15.14
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 6
|
39.66 score on a scale
Standard Deviation 16.43
|
39.39 score on a scale
Standard Deviation 14.87
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 9
|
41.04 score on a scale
Standard Deviation 15.49
|
38.29 score on a scale
Standard Deviation 15.04
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 12
|
40.01 score on a scale
Standard Deviation 17.60
|
35.48 score on a scale
Standard Deviation 15.39
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 15
|
41.23 score on a scale
Standard Deviation 16.50
|
35.75 score on a scale
Standard Deviation 16.18
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Month 18
|
35.25 score on a scale
Standard Deviation 17.00
|
31.66 score on a scale
Standard Deviation 14.61
|
|
Post-Traumatic Stress Disorder (PTSD) Civilian Checklist 5 (PCL-5) Score
Baseline
|
46.98 score on a scale
Standard Deviation 14.70
|
48.33 score on a scale
Standard Deviation 15.66
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The Patient Health Questionnaire (PHQ-9) assesses the severity of depression (Kroenke, et al., 2002). It consists of 9 depression symptom questions with response choices of 0 (not at all), 1 (several days), 2 (more than half of days), or 3 (nearly every day). The total score is calculated by adding together the symptom ratings for each of the 9 questions so that scores range from 0 to 27 (higher scores represent greater depression severity).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Patient Health Questionnaire (PHQ-9) Score
Baseline
|
13.08 score on a scale
Standard Deviation 5.94
|
12.79 score on a scale
Standard Deviation 5.85
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 9
|
11.53 score on a scale
Standard Deviation 6.18
|
9.52 score on a scale
Standard Deviation 4.80
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 12
|
11.03 score on a scale
Standard Deviation 6.31
|
9.97 score on a scale
Standard Deviation 5.65
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 15
|
11.47 score on a scale
Standard Deviation 6.20
|
9.67 score on a scale
Standard Deviation 5.79
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 18
|
9.43 score on a scale
Standard Deviation 6.24
|
8.19 score on a scale
Standard Deviation 4.45
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 3
|
11.46 score on a scale
Standard Deviation 6.05
|
10.95 score on a scale
Standard Deviation 5.47
|
|
Patient Health Questionnaire (PHQ-9) Score
Month 6
|
10.55 score on a scale
Standard Deviation 6.03
|
10.03 score on a scale
Standard Deviation 5.07
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The 7-item Dimensions of Anger Reactions (DAR) is a seven-item scale that assesses anger disposition directed to others (Forbes, et al.,2004). For each item, participants indicate the degree to which each statement describes their feelings and behavior on an 8-point scale ranging from 0 (not at all) to 8 (exactly so). Scores are totaled yielding a range of 0 to 56 with higher scores indicating greater anger disposition.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Dimensions of Anger Reactions (DAR) Score
Baseline
|
23.82 score on a scale
Standard Deviation 14.64
|
21.85 score on a scale
Standard Deviation 15.07
|
|
Dimensions of Anger Reactions (DAR) Score
Month 3
|
23.21 score on a scale
Standard Deviation 15.87
|
22.14 score on a scale
Standard Deviation 14.28
|
|
Dimensions of Anger Reactions (DAR) Score
Month 6
|
21.05 score on a scale
Standard Deviation 16.32
|
20.35 score on a scale
Standard Deviation 13.75
|
|
Dimensions of Anger Reactions (DAR) Score
Month 9
|
23.97 score on a scale
Standard Deviation 16.16
|
19.52 score on a scale
Standard Deviation 13.22
|
|
Dimensions of Anger Reactions (DAR) Score
Month 12
|
22.97 score on a scale
Standard Deviation 15.57
|
18.58 score on a scale
Standard Deviation 14.75
|
|
Dimensions of Anger Reactions (DAR) Score
Month 15
|
22.32 score on a scale
Standard Deviation 16.91
|
17.47 score on a scale
Standard Deviation 14.24
|
|
Dimensions of Anger Reactions (DAR) Score
Month 18
|
20.15 score on a scale
Standard Deviation 16.63
|
15.90 score on a scale
Standard Deviation 14.37
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
The Suicidal Behavior or Ideation (SBI) indicator derived from the Columbia Suicide Severity Rating Scale (C-SSRS) is dichotomized as the presence or absence of suicidal behavior or ideation. Presence of SBI is indicated by a "Yes" response to any one of the five suicidal behavior or the five suicidal ideation questions.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Baseline
|
13 Participants
|
24 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 3
|
22 Participants
|
33 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 6
|
19 Participants
|
21 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 9
|
19 Participants
|
22 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 12
|
20 Participants
|
25 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 15
|
21 Participants
|
20 Participants
|
|
Number of Participants Reporting Suicidal Behavior or Ideation (SBI) Derived From the Columbia Suicide Severity Rating Scale (C-SSRS)
Month 18
|
18 Participants
|
13 Participants
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
Non-Veterans Administration (VA) healthcare utilization will be assessed using the "HERC non-VA utilization survey." This survey was created in 2011 by VA Health Economics Resource Center (HERC) investigators. The HERC non-VA utilization survey is self-administered and asks about outpatient and inpatient (including Emergency Room) visits to non-VA healthcare and/or non-VA mental health providers. Sample size (n) reflects the number of participants who provided self-reported non-VA healthcare use information at the time of data collection.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Baseline
|
1.6 number of visits
Standard Deviation 3.8
|
1.1 number of visits
Standard Deviation 4.8
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 3
|
0.9 number of visits
Standard Deviation 2.6
|
0.5 number of visits
Standard Deviation 1.3
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 6
|
1.0 number of visits
Standard Deviation 2.8
|
0.4 number of visits
Standard Deviation 1.4
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 9
|
1.3 number of visits
Standard Deviation 3.5
|
0.5 number of visits
Standard Deviation 1.5
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 12
|
0.9 number of visits
Standard Deviation 2.7
|
0.7 number of visits
Standard Deviation 2.5
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 15
|
1.4 number of visits
Standard Deviation 3.3
|
0.5 number of visits
Standard Deviation 1.5
|
|
Number of Outpatient Visits to Non-Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Month 18
|
0.9 number of visits
Standard Deviation 2.1
|
0.6 number of visits
Standard Deviation 1.8
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
Non-Veterans Administration (VA) healthcare utilization will be assessed using the "HERC non-VA utilization survey." This survey was created in 2011 by VA Health Economics Resource Center (HERC) investigators. The HERC non-VA utilization survey is self-administered and asks about outpatient and inpatient (including Emergency Room) visits to non-VA healthcare and/or non-VA mental health providers. Sample size (n) reflects the number of participants who provided self-reported non-VA healthcare use information at the time of data collection.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 3
|
0.1 number of visits
Standard Deviation 0.3
|
0.0 number of visits
Standard Deviation 0.2
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 6
|
0.1 number of visits
Standard Deviation 0.3
|
0.0 number of visits
Standard Deviation 0.2
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Baseline
|
0.1 number of visits
Standard Deviation 0.4
|
0.1 number of visits
Standard Deviation 0.3
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 9
|
0.1 number of visits
Standard Deviation 0.6
|
0.1 number of visits
Standard Deviation 0.3
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 12
|
0.1 number of visits
Standard Deviation 0.4
|
0.1 number of visits
Standard Deviation 0.3
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 15
|
0.1 number of visits
Standard Deviation 0.3
|
0.0 number of visits
Standard Deviation 0.2
|
|
Number of Emergency Room Visits to Non-Veterans Administration (VA) Facilities
Month 18
|
0.1 number of visits
Standard Deviation 0.3
|
0.1 number of visits
Standard Deviation 0.3
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog. The number of participants analyzed at each 3-month follow-up time point represents the number of individuals still participating in the study at that time point and completing the assessment. As this was a longitudinal study, attrition was expected and seen over time. Reasons for attrition are noted in the Participant Flow section under the 'Pairing With a Study Dog' Period.
Non-Veterans Administration (VA) healthcare utilization will be assessed using the "HERC non-VA utilization survey." This survey was created in 2011 by VA Health Economics Resource Center (HERC) investigators. The HERC non-VA utilization survey is self-administered and asks about outpatient and inpatient (including Emergency Room) visits to non-VA healthcare and/or non-VA mental health providers. Sample size (n) reflects the number of participants who provided self-reported non-VA healthcare use information at the time of data collection.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Percentage of Participants With a Non-VA Hospitalization
Baseline
|
0 Percentage of participants
Standard Deviation 0
|
6 Percentage of participants
Standard Deviation 24
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 3
|
3 Percentage of participants
Standard Deviation 16
|
5 Percentage of participants
Standard Deviation 23
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 6
|
5 Percentage of participants
Standard Deviation 23
|
2 Percentage of participants
Standard Deviation 15
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 9
|
3 Percentage of participants
Standard Deviation 17
|
8 Percentage of participants
Standard Deviation 27
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 12
|
3 Percentage of participants
Standard Deviation 17
|
3 Percentage of participants
Standard Deviation 18
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 15
|
0 Percentage of participants
Standard Deviation 0
|
1 Percentage of participants
Standard Deviation 11
|
|
Percentage of Participants With a Non-VA Hospitalization
Month 18
|
0 Percentage of participants
Standard Deviation 0
|
2 Percentage of participants
Standard Deviation 15
|
SECONDARY outcome
Timeframe: 540 days starting on the pairing date; summarized into six 90-day periodsPopulation: Participants randomized and paired with an emotional support dog or a service dog.
Utilization of VA outpatient services, identified using VA administrative data. The investigators identified all VA utilization and cost data for the 540 days (i.e., 18 months) starting on the date of pairing for each participant and summarized the data into six 90-day periods.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 361-450
|
14.2 number of visits
Standard Deviation 8.7
|
13.8 number of visits
Standard Deviation 10.5
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 451-540
|
14.8 number of visits
Standard Deviation 10.7
|
13 number of visits
Standard Deviation 9.8
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Baseline (90 days prior to pairing)
|
16.4 number of visits
Standard Deviation 9.1
|
15.2 number of visits
Standard Deviation 10.6
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 1-90
|
15.1 number of visits
Standard Deviation 9.3
|
15.1 number of visits
Standard Deviation 11.3
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 91-180
|
14.5 number of visits
Standard Deviation 9.1
|
15 number of visits
Standard Deviation 9.8
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 181-270
|
14.5 number of visits
Standard Deviation 10.1
|
14.4 number of visits
Standard Deviation 11.2
|
|
Number of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers.
Days 271-360
|
13.4 number of visits
Standard Deviation 8.5
|
13.4 number of visits
Standard Deviation 9.8
|
SECONDARY outcome
Timeframe: 540 days starting on the pairing date; summarized into six 90-day periodsPopulation: Participants randomized and paired with an emotional support dog or a service dog
Utilization of VA inpatient services, identified using VA administrative data. The investigators identified all VA utilization and cost data for the 540 days (i.e., 18 months) starting on the date of pairing for each participant and summarized the data into six 90-day periods.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Baseline (90 days prior to pairing)
|
0 Number of inpatient admissions
Standard Deviation 0.1
|
0.1 Number of inpatient admissions
Standard Deviation 0.3
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 1-90
|
0 Number of inpatient admissions
Standard Deviation 0.1
|
0.1 Number of inpatient admissions
Standard Deviation 0.3
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 91-180
|
0 Number of inpatient admissions
Standard Deviation 0.2
|
0 Number of inpatient admissions
Standard Deviation 0.2
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 181-270
|
0 Number of inpatient admissions
Standard Deviation 0.3
|
0.1 Number of inpatient admissions
Standard Deviation 0.3
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 271-360
|
0 Number of inpatient admissions
Standard Deviation 0.1
|
0 Number of inpatient admissions
Standard Deviation 0.2
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 361-450
|
0.1 Number of inpatient admissions
Standard Deviation 0.3
|
0.1 Number of inpatient admissions
Standard Deviation 0.4
|
|
Number of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 451-540
|
0 Number of inpatient admissions
Standard Deviation 0.3
|
0 Number of inpatient admissions
Standard Deviation 0.1
|
SECONDARY outcome
Timeframe: 540 days starting on the pairing date; summarized into six 90-day periodsPopulation: Participants randomized and paired with an emotional support dog or a service dog
Cost of VA outpatient services, identified using VA administrative data. The investigators identified all VA utilization and cost data for the 540 days (i.e., 18 months) starting on the date of pairing for each participant and summarized the data into six 90-day periods.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Baseline (90 days prior to pairing)
|
4701.32 U.S. dollars
Standard Deviation 4714.98
|
4496.76 U.S. dollars
Standard Deviation 4547.64
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 1-90
|
3997.82 U.S. dollars
Standard Deviation 3433.71
|
4696.70 U.S. dollars
Standard Deviation 4363.93
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 91-180
|
3684.87 U.S. dollars
Standard Deviation 3295.50
|
4579.89 U.S. dollars
Standard Deviation 4833.31
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 271-360
|
3494.07 U.S. dollars
Standard Deviation 3840.25
|
4025.24 U.S. dollars
Standard Deviation 4438.57
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 361-450
|
3762.58 U.S. dollars
Standard Deviation 3886.48
|
4043.37 U.S. dollars
Standard Deviation 4333.64
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 451-540
|
3685.47 U.S. dollars
Standard Deviation 4648.30
|
3449.97 U.S. dollars
Standard Deviation 4099.49
|
|
Total Cost of Outpatient Visits to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 181-270
|
3869.49 U.S. dollars
Standard Deviation 4358.85
|
4360.64 U.S. dollars
Standard Deviation 4602.07
|
SECONDARY outcome
Timeframe: 540 days starting on the pairing date; summarized into six 90-day periodsPopulation: Participants randomized and paired with an emotional support dog or a service dog
Cost of VA inpatient services, identified using VA administrative data. The investigators identified all VA utilization and cost data for the 540 days (i.e., 18 months) starting on the date of pairing for each participant and summarized the data into six 90-day periods.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Baseline (90 days prior to pairing)
|
184.53 U.S. dollars
Standard Deviation 1701.29
|
1341.99 U.S. dollars
Standard Deviation 7621.15
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 271-360
|
70.04 U.S. dollars
Standard Deviation 456.89
|
1403.54 U.S. dollars
Standard Deviation 6648.71
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 1-90
|
132.36 U.S. dollars
Standard Deviation 1220.31
|
727.11 U.S. dollars
Standard Deviation 3513.19
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 91-180
|
803.92 U.S. dollars
Standard Deviation 5758.11
|
567.10 U.S. dollars
Standard Deviation 3690.03
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 181-270
|
1182.46 U.S. dollars
Standard Deviation 8807.28
|
1219.27 U.S. dollars
Standard Deviation 8693.99
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days 361-450
|
916.85 U.S. dollars
Standard Deviation 5527.54
|
1174.82 U.S. dollars
Standard Deviation 6770.73
|
|
Total Cost of Inpatient Admissions to Veterans Administration (VA) Healthcare Providers or Mental Health Providers
Days (451-540)
|
439.40 U.S. dollars
Standard Deviation 2943.53
|
333.03 U.S. dollars
Standard Deviation 2311.15
|
SECONDARY outcome
Timeframe: 540 days starting on the pairing date; summarized into six 90-day periodsPopulation: Participants randomized and paired with an emotional support dog or a service dog
Cost of VA inpatient and outpatient services, identified using VA administrative data. The investigators identified all VA utilization and cost data for the 540 days (i.e., 18 months) starting on the date of pairing for each participant and summarized the data into six 90-day periods.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 181-270
|
5051.95 U.S. dollars
Standard Deviation 10019.56
|
5579.91 U.S. dollars
Standard Deviation 9864.29
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 271-360
|
3564.11 U.S. dollars
Standard Deviation 3895.45
|
5428.78 U.S. dollars
Standard Deviation 8514.41
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 361-450
|
4679.42 U.S. dollars
Standard Deviation 7081.99
|
5218.19 U.S. dollars
Standard Deviation 8398.77
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 451-540
|
4124.87 U.S. dollars
Standard Deviation 6196.64
|
3782.99 U.S. dollars
Standard Deviation 4929.90
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Baseline (90 days prior to pairing)
|
4885.85 U.S. dollars
Standard Deviation 5043.26
|
5838.74 U.S. dollars
Standard Deviation 9613.11
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 1-90
|
4130.18 U.S. dollars
Standard Deviation 3637.66
|
5423.80 U.S. dollars
Standard Deviation 6612.74
|
|
Total Cost of VA Healthcare (Inpatient and Outpatient)
Days 91-180
|
4488.79 U.S. dollars
Standard Deviation 7642.83
|
5146.99 U.S. dollars
Standard Deviation 7084.47
|
SECONDARY outcome
Timeframe: Baseline: The 540 days prior to pairing Follow up: Pairing through day 540Population: Participants with at least one refill in the drug class randomized and paired with an emotional support dog or a service dog
The investigators calculated Proportion of Days Covered (PDC) to measure medication adherence for common psychiatric medications dispensed by VA. Using the VA Drug Class variable, the investigators categorized medications into four categories: antidepressants (CN600-CN699), antipsychotics (CN700-CN799), benzodiazepine (CN302), and other hypnotics and sedatives (CN300, CN301, CN309). PDC for antidepressants are reported for this outcome (as a percentage).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Percentage of Days Covered for Antidepressants
Baseline
|
78.10 Percentage of days
Standard Deviation 21.60
|
73.90 Percentage of days
Standard Deviation 23.20
|
|
Percentage of Days Covered for Antidepressants
Follow up
|
70.50 Percentage of days
Standard Deviation 20.80
|
77.20 Percentage of days
Standard Deviation 21.80
|
SECONDARY outcome
Timeframe: Baseline: The 540 days prior to pairing Follow up: Pairing through day 540Population: Participants with at least one refill in the drug class randomized and paired with an emotional support dog or a service dog
The investigators calculated Proportion of Days Covered (PDC) to measure medication adherence for common psychiatric medications dispensed by VA. Using the VA Drug Class variable, the investigators categorized medications into four categories: antidepressants (CN600-CN699), antipsychotics (CN700-CN799), benzodiazepine (CN302), and other hypnotics and sedatives (CN300, CN301, CN309). PDC for antipsychotics are reported for this outcome (as a percentage).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Percentage of Days Covered for Antipsychotics
Baseline
|
79.00 Percentage of days
Standard Deviation 22.40
|
72.30 Percentage of days
Standard Deviation 20.90
|
|
Percentage of Days Covered for Antipsychotics
Follow up
|
71.40 Percentage of days
Standard Deviation 28.50
|
76.30 Percentage of days
Standard Deviation 17.40
|
SECONDARY outcome
Timeframe: Baseline: The 540 days prior to pairing Follow up: Pairing through day 540Population: Participants with at least one refill in the drug class randomized and paired with an emotional support dog or a service dog
The investigators calculated Proportion of Days Covered (PDC) to measure medication adherence for common psychiatric medications dispensed by VA. Using the VA Drug Class variable, the investigators categorized medications into four categories: antidepressants (CN600-CN699), antipsychotics (CN700-CN799), benzodiazepine (CN302), and other hypnotics and sedatives (CN300, CN301, CN309). PDC for benzodiazepines are reported for this outcome (as a percentage).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Percentage of Days Covered for Benzodiazepines
Follow up
|
54.80 Percentage of days
Standard Deviation 28.30
|
60.10 Percentage of days
Standard Deviation 29.30
|
|
Percentage of Days Covered for Benzodiazepines
Baseline
|
61.60 Percentage of days
Standard Deviation 25.60
|
72.60 Percentage of days
Standard Deviation 26.60
|
SECONDARY outcome
Timeframe: Baseline: The 540 days prior to pairing Follow up: Pairing through day 540Population: Participants with at least one refill in the drug class randomized and paired with an emotional support dog or a service dog
The investigators calculated Proportion of Days Covered (PDC) to measure medication adherence for common psychiatric medications dispensed by VA. Using the VA Drug Class variable, the investigators categorized medications into four categories: antidepressants (CN600-CN699), antipsychotics (CN700-CN799), benzodiazepine (CN302), and other hypnotics and sedatives (CN300, CN301, CN309). PDC for other sedatives are reported for this outcome (as a percentage).
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Percentage of Days Covered for Other Sedatives
Baseline
|
66.90 Percentage of days
Standard Deviation 30.90
|
63.20 Percentage of days
Standard Deviation 25.30
|
|
Percentage of Days Covered for Other Sedatives
Follow up
|
79.10 Percentage of days
Standard Deviation 27.80
|
63.00 Percentage of days
Standard Deviation 21.50
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog
Employment assessed using the question "Are you currently employed (working for pay)?" from the Work Productivity and Activity Impairment Questionnaire: General Health Problem V2.0 (WPAI V2.0; Reilly et al, 1993). Sample size (n) reflects the number of participants who provided work productivity and employment information at the time of data collection.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Number of Veterans Employed
Baseline
|
28 Participants
|
25 Participants
|
|
Number of Veterans Employed
Month 3
|
27 Participants
|
22 Participants
|
|
Number of Veterans Employed
Month 6
|
23 Participants
|
23 Participants
|
|
Number of Veterans Employed
Month 9
|
20 Participants
|
22 Participants
|
|
Number of Veterans Employed
Month 12
|
19 Participants
|
21 Participants
|
|
Number of Veterans Employed
Month 15
|
18 Participants
|
25 Participants
|
|
Number of Veterans Employed
Month 18
|
17 Participants
|
21 Participants
|
SECONDARY outcome
Timeframe: Baseline and every 3 months after dog pairing up to 18 months post-pairingPopulation: Participants randomized and paired with an emotional support dog or a service dog
Impact of Health on Work Productivity was assessed using the Work Productivity and Activity Impairment Questionnaire: General Health Problem V2.0 (WPAI V2.0; Reilly et al, 1993). Only participants who were employed were included in this analysis. Scores can range from 0 (no impact of health on work productivity) to 10 (extreme impact of health on work productivity), so a higher score represents a greater impact of health on work productivity.
Outcome measures
| Measure |
Emotional Support Dogs
n=84 Participants
Participants paired with Emotional Support Dogs
Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
|
Service Dogs
n=97 Participants
Participants paired with Service Dogs
Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
|
|---|---|---|
|
Impact of Health on Work Productivity Score
Baseline
|
5.7 score on a scale
Standard Deviation 2.6
|
3.3 score on a scale
Standard Deviation 2.2
|
|
Impact of Health on Work Productivity Score
Month 9
|
3.9 score on a scale
Standard Deviation 2.9
|
2.7 score on a scale
Standard Deviation 2.8
|
|
Impact of Health on Work Productivity Score
Month 12
|
3.1 score on a scale
Standard Deviation 2.6
|
3.4 score on a scale
Standard Deviation 2.6
|
|
Impact of Health on Work Productivity Score
Month 18
|
2.7 score on a scale
Standard Deviation 2.2
|
3.7 score on a scale
Standard Deviation 2.3
|
|
Impact of Health on Work Productivity Score
Month 3
|
4.7 score on a scale
Standard Deviation 2.6
|
3.4 score on a scale
Standard Deviation 2.8
|
|
Impact of Health on Work Productivity Score
Month 6
|
4.1 score on a scale
Standard Deviation 2.7
|
3.1 score on a scale
Standard Deviation 2.9
|
|
Impact of Health on Work Productivity Score
Month 15
|
3.6 score on a scale
Standard Deviation 2.2
|
3 score on a scale
Standard Deviation 2.9
|
Adverse Events
Emotional Support Dog
Service Dog
Prior to Dog Pairing
Serious adverse events
| Measure |
Emotional Support Dog
n=84 participants at risk
Participants randomized and paired to receive an Emotional Support Dog
Emotional Support Dog - a dog that has earned AKC Good Canine Citizen certification and provides emotional support and comfort to the Veteran.
|
Service Dog
n=97 participants at risk
Participants randomized and paired to receive a Service Dog
Service Dog - an assistance dog specifically trained to perform tasks that are specific to the person's disability and has public access privileges.
|
Prior to Dog Pairing
n=287 participants at risk
All participants consented regardless of whether eventually randomized and paired with a dog.
|
|---|---|---|---|
|
Cardiac disorders
Angina pectoris
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Angina unstable
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Atrial fibrillation
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Atrioventricular block
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Cardiac failure
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Cardiac failure congestive
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Coronary artery disease
|
2.4%
2/84 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Myocardial infarction
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Postural orthostatic tachycardia syndrome
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Prinzmetal angina
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Cardiac disorders
Sinus tachycardia
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Ear and labyrinth disorders
Vertigo
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Gastrointestinal disorders
Gastritis alcoholic
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Gastrointestinal disorders
Pancreatitis
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
General disorders
Chest discomfort
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
General disorders
Chest pain
|
2.4%
2/84 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
2.1%
2/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
General disorders
Non-cardiac chest pain
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Hepatobiliary disorders
Hepatic cirrhosis
|
1.2%
1/84 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Diverticulitis
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Ear infection
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Infected skin ulcer
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Pneumonia
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
2.1%
2/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Post procedural infection
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Tooth abscess
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Cardiac procedure complication
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Fall
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Investigations
Heart rate decreased
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Metabolism and nutrition disorders
Dehydration
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
2.1%
2/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Metabolism and nutrition disorders
Diabetes mellitus inadequate control
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Musculoskeletal and connective tissue disorders
Intervertebral disc compression
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Musculoskeletal and connective tissue disorders
Osteoarthritis
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Musculoskeletal and connective tissue disorders
Vertebral foraminal stenosis
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung neoplasm malignant
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate cancer
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Nervous system disorders
Cerebral haemorrhage
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Nervous system disorders
Cerebrovascular accident
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Nervous system disorders
Cervical radiculopathy
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Nervous system disorders
Loss of consciousness
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Nervous system disorders
Transient ischaemic attack
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
3.1%
3/97 • Number of events 4 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Alcohol abuse
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 3 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Alcoholism
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Anxiety
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.70%
2/287 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Depression
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.70%
2/287 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Drug use disorder
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Post-traumatic stress disorder
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Substance use disorder
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Suicidal ideation
|
3.6%
3/84 • Number of events 3 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
6.2%
6/97 • Number of events 7 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.70%
2/287 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Suicide attempt
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Renal and urinary disorders
Acute kidney injury
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Respiratory, thoracic and mediastinal disorders
Chronic obstructive pulmonary disease
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Social circumstances
Social stay hospitalisation
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Alcohol detoxification
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Cardiac pacemaker insertion
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Heart valve replacement
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Knee arthroplasty
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Liposuction
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Metabolic surgery
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Plastic surgery
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Rehabilitation therapy
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Spinal decompression
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Surgical and medical procedures
Spinal operation
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Vascular disorders
Hypertension
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
1.0%
1/97 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
Other adverse events
| Measure |
Emotional Support Dog
n=84 participants at risk
Participants randomized and paired to receive an Emotional Support Dog
Emotional Support Dog - a dog that has earned AKC Good Canine Citizen certification and provides emotional support and comfort to the Veteran.
|
Service Dog
n=97 participants at risk
Participants randomized and paired to receive a Service Dog
Service Dog - an assistance dog specifically trained to perform tasks that are specific to the person's disability and has public access privileges.
|
Prior to Dog Pairing
n=287 participants at risk
All participants consented regardless of whether eventually randomized and paired with a dog.
|
|---|---|---|---|
|
Immune system disorders
Allergy to animal
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Infections and infestations
Infestation
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Animal bite
|
1.2%
1/84 • Number of events 2 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Fall
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Joint injury
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Injury, poisoning and procedural complications
Limb injury
|
1.2%
1/84 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/287 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
|
Psychiatric disorders
Emotional distress
|
0.00%
0/84 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.00%
0/97 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
0.35%
1/287 • Number of events 1 • Serious adverse events (SAE) were assessed continuously from the time of a participant's consent up to 19 months post-pairing (18 months post-pairing + 30 days). Other (non-SAE) adverse events were collected starting from dog pairing until up to 19 months post-pairing (18 months post-pairing + 30 days).
For participants consented, all SAEs were collected. Other AEs were collected if possibly or definitely related to the intervention. Events AFTER pairing are reported under the randomized treatment group. Events BEFORE pairing are in the Prior to Dog Pairing group. Participants with an event in the Prior to Dog Pairing group may have an event reported in a treatment group. One SAE with a partial missing date is believed to have occurred prior to pairing and is in "Prior to Dog Pairing" group.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place